American Dental Association issues updated oral cancer detection guidelines

The American Dental Association (ADA) has released updated clinical guidelines for the early detection of oral cavity cancer and potentially malignant disorders. These recommendations replace the previous 2017 version and represent the first guidelines developed under the ADA Living Guideline Program, designed to incorporate new evidence as it emerges.

The guidelines emphasize that comprehensive clinical examinations—including both intraoral and extraoral visual and palpation assessments—remain the fundamental tool for detection. Dental professionals are encouraged to conduct thorough screenings during routine visits and to maintain detailed medical, dental, and social histories for patients.

If oral mucosal abnormalities do not resolve within 10 to 14 days following an initial evaluation, the ADA recommends a biopsy or referral to a specialist, noting that biopsy is the only definitive method to confirm a diagnosis. While various diagnostic technologies exist, the ADA advises against using light-based vital staining and salivary adjunct tests for routine screening; salivary tests are currently recommended only for research settings. Cytology may be used when a biopsy is not possible or indicated.